GIST Panel Test: Booking, Price, and Results
About GIST Panel Test: Booking, Price, and Results
| Field | Value |
|---|---|
| Also Known As | GIST IHC Panel, Gastrointestinal Stromal Tumour Immunohistochemistry Panel |
| Sample Type | Tissue biopsy (formalin-fixed paraffin-embedded block) |
| Fasting Required | No |
| Report Time | 1 day |
| Recommended For | All genders and ages; patients with suspected gastrointestinal mesenchymal tumours |
| Price | Starting at ₹22,400 |
What Is a GIST Panel Test?
The GIST panel test is a specialised laboratory investigation used to diagnose gastrointestinal stromal tumours (GISTs), which are the most common mesenchymal tumours of the digestive tract. The test uses a technique called immunohistochemistry (IHC), where specific antibodies are applied to a tissue sample to detect the presence or absence of key proteins on tumour cells. It is also known as the GIST IHC panel or gastrointestinal stromal tumour immunohistochemistry panel. A tissue biopsy sample is required for this test.
What Does a GIST Panel Test Measure?
The GIST panel test procedure analyses a tissue sample for a set of protein markers. Each marker helps confirm or rule out a GIST diagnosis and distinguish it from other tumour types. The panel tested at Lupin Diagnostics covers seven markers:
| Marker | What It Detects |
|---|---|
| CD117 (KIT) | A protein found in approximately 95% of GISTs; its presence strongly suggests GIST |
| DOG1 (Discovered on GIST-1) | A highly sensitive marker covering nearly 99% of GISTs; particularly useful when CD117 is absent |
| ERBB2 | A receptor protein assessed to support tumour characterisation |
| KIT (mutation analysis) | Evaluates KIT gene alterations that drive tumour growth |
| BRAF | Assessed for mutations that may guide targeted treatment decisions |
| PDGFRA | A receptor gene commonly mutated in CD117-negative GISTs |
| TP53 | A tumour suppressor gene; its mutation status helps with risk assessment |
Why Is a GIST Panel Test Done?
A doctor may order the GIST panel test when a patient presents with symptoms or imaging findings suggesting a tumour in the gastrointestinal tract. The panel helps confirm whether the tumour is a GIST and distinguishes it from other look-alike conditions.
Common Symptoms That May Require This Test
The following symptoms may prompt a doctor to investigate for GIST:
- Persistent abdominal pain or discomfort
- Blood in stools or vomiting blood
- Unexplained fatigue and weakness caused by low red blood cell count
- Nausea, bloating, or feeling full quickly after eating
- Unexplained weight loss
- A palpable lump or mass in the abdomen
Conditions This Test Can Help Detect
This panel is used to identify or distinguish between the following conditions:
- Gastrointestinal stromal tumours arising in the stomach, small intestine, colon, rectum, or oesophagus
- Leiomyoma and leiomyosarcoma (benign and malignant smooth muscle tumours)
- Schwannoma (a nerve sheath tumour)
- Other spindle cell or mesenchymal tumours of the gastrointestinal tract
How to Prepare and What to Expect
The GIST panel test procedure differs from routine blood tests because it is performed on a tissue sample, not a blood draw. Knowing what to expect can help you prepare.
Do You Need to Fast?
No fasting is required. This test is performed on a tissue biopsy sample and does not involve any blood draw. However, if a biopsy procedure is planned, your doctor may give you separate pre-procedure instructions, including fasting before sedation or anaesthesia. Always follow any specific instructions provided by your doctor.
Practical Tips Before Your Test
Being well prepared helps the process go smoothly. Keep these points in mind:
- Bring a detailed clinical history including your symptoms, previous test results, and family history, as this is required for the test
- Carry all previous imaging reports such as CT scans, MRIs, or endoscopy findings for the pathologist's reference
- Inform your doctor about all current medications, including blood thinners, before any biopsy procedure
- Follow all pre-biopsy instructions given by your treating doctor or surgeon
Step-by-Step Procedure
Here is how the GIST panel test procedure typically works from biopsy to result:
- A biopsy is performed by a specialist. This may involve an upper endoscopy, an endoscopic ultrasound-guided fine needle aspiration (EUS-FNA), a CT-guided core needle biopsy, or surgical excision, depending on the tumour's location.
- The collected tissue is placed in a formalin solution to preserve it. It is then embedded in a paraffin block for processing.
- Thin sections are cut from the paraffin block and mounted on glass slides.
- A pathologist applies specific antibodies to the slides. The antibodies bind to their target proteins and produce visible colour staining.
- The stained slides are examined under a microscope. The pathologist assesses the intensity and extent of staining for each marker.
- A detailed pathology report is prepared and sent to your doctor within the stated turnaround time.
Factors That Can Affect Accuracy
Several factors may influence the quality and reliability of test results:
- Delay between tissue collection and fixation in formalin
- Inadequate tissue volume from the biopsy
- Presence of extensive cell death (necrosis) in the sample
- Variation in fixation time or processing protocols
- Quality of antibodies and laboratory techniques used
Understanding Your GIST Panel Test Results
Results from the GIST panel test should always be reviewed with a qualified doctor, as interpretation depends on the full clinical context. The table below outlines the expected pattern of markers in GISTs compared to other tumour types:
| Marker | Expected Finding in GIST | What It Suggests |
|---|---|---|
| CD117 (c-KIT protein) | Positive (approximately 95% of GISTs) | Strongly supports GIST diagnosis |
| DOG1 | Positive (approximately 99% of GISTs) | Highly specific for GIST; useful when CD117 is negative |
| KIT (gene mutation) | Activating mutation in most GISTs (commonly exons 9, 11, 13, 17) | Confirms primary oncogenic driver and predicts response to tyrosine kinase inhibitors |
| PDGFRA | Mutated in a subset of GISTs, often CD117-negative cases | Confirms GIST subtype; some variants may show drug resistance |
| BRAF | Rare mutation (e.g., V600E) in a small subset of GISTs | Indicates alternative oncogenic pathway; may guide targeted therapy options |
| ERBB2 (HER2) | Rare amplification or overexpression in GIST | Suggests potential eligibility for HER2-targeted therapy in select cases |
| TP53 | Mutation in a subset of higher-risk or advanced tumors | Associated with tumor progression and aggressive behavior |
These ranges are general guidelines. Your doctor will interpret your results based on your age, health history, and other factors. Always consult a qualified healthcare professional for personalised medical advice.
Results During Special Conditions
Certain situations can make result interpretation more complex:
- Patients who have already received tyrosine kinase inhibitor therapy may show reduced or absent expression of CD117 and DOG1, which can make it harder to confirm recurrent or persistent disease on a repeat biopsy.
- Poorly fixed or degraded tissue samples may produce false-negative results across multiple markers, so sample quality is critical to accurate reporting.
How to Maintain Healthy Levels
GISTs cannot be prevented through diet or lifestyle changes. However, the following general steps support early detection and better outcomes:
- Seek prompt medical evaluation if you notice persistent abdominal symptoms, as early detection leads to better outcomes
- Attend all follow-up appointments with your oncologist or gastroenterologist if a tumour has been identified
- Maintain a balanced diet and healthy weight, which supports general digestive and immune health
Lupin Diagnostics GIST Panel Test Price and Home Collection
The GIST panel test cost at Lupin Diagnostics starts at ₹22,400. This test requires a visit to a Lupin Diagnostics centre or submission of a biopsy block through your treating doctor. Home collection is not available for this test, as it requires a tissue sample obtained through a clinical biopsy procedure.
| City | Approximate Price (₹) |
|---|---|
| BHOPAL | 22400 |
| CHENNAI | 22400 |
| HYDERABAD | 22400 |
| KOLKATA | 22400 |
| NAVI MUMBAI | 22400 |
| PUNE | 22400 |
Prices are indicative and may vary by location. Please confirm the current price at the time of booking.
How to Book
Follow these steps for GIST panel test online booking:
- Select the GIST Panel Test on the Lupin Diagnostics website.
- Choose your city and preferred time slot.
- Opt for home sample collection by a certified phlebotomist, or visit your nearest Lupin Diagnostics centre.
- Receive your report via email or WhatsApp within the stipulated turnaround time.
Frequently Asked Questions
The GIST panel test is used to confirm whether a tumour in the gastrointestinal tract is a gastrointestinal stromal tumour. It analyses a set of protein markers in biopsy tissue using immunohistochemistry and molecular methods. This helps distinguish GIST from other similar-looking tumours and guides treatment planning.
The sample is obtained through a biopsy procedure. This may involve an upper endoscopy, an endoscopic ultrasound-guided biopsy, a CT-guided needle biopsy, or surgical removal of tumour tissue. The method depends on where the tumour is located. Your specialist will decide the most appropriate approach for you.
Using a panel of markers rather than a single test improves diagnostic accuracy. Different markers help confirm GIST while ruling out other tumour types such as smooth muscle tumours and nerve sheath tumours. The combination of CD117, DOG1, and molecular markers like PDGFRA together covers the vast majority of GIST cases.
No. The GIST panel test requires a tissue biopsy sample, which cannot be collected at home. The biopsy is performed at a hospital or diagnostic centre by a trained specialist. Your tissue block or slides are then submitted to the laboratory for processing.
A positive CD117 result strongly supports a diagnosis of GIST, as approximately 95% of GISTs express this protein. When combined with a positive DOG1 result, it provides high diagnostic confidence. Your pathologist and oncologist will review the full panel together before reaching a conclusion.
Yes, in a small number of cases. Approximately 4 to 10% of GISTs express little or no CD117. To account for this, the panel includes DOG1 and molecular markers, which together improve overall accuracy to more than 98% of cases. Your doctor will consider all markers together, not just one result in isolation.
GIST Panel Test: Booking, Price, and Results
